Herpes simplex virus type-2 specific glycoprotein G-2 immunomagnetically captured from HEp-2 infected tissue culture extracts

Journal of Virological Methods

Volumn 119, Issue 2, 2004, Pages 121-128

  Clavet, Charles R ^a   Margolin, Aaron B ^b   Regan, Patrick M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

Glycoprotein G 2; HSV 2; Immunomagnetic separation; Type specific gG 2

Indexed keywords

THROMBOSPONDIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; EVALUATION; EXTRACTION; HELIX POMATIA; HERPES SIMPLEX VIRUS 2; IMMUNOBLOTTING; IMMUNOMAGNETIC SEPARATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SOLUBILIZATION; TISSUE CULTURE CELL; VIRUS ISOLATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; CELL LINE; HUMANS; IMMUNOMAGNETIC SEPARATION; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

HELIX POMATIA; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 2442647456     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.03.008     Document Type: Article

References (47)

1. Ackerman M., Longnecker R., Roizman B., Pereira L. Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology. 150:1986;207-220
2. Ashley R. Sorting out the new HSV type specific antibody tests. Sex Trans. Inf. 77:2001;232-237
3. Ashley R. Performance and use of HSV type-specific serology test kits. Herpes. 9:2002;38-45
4. Ashley R.L., Cent A., Maggs V., Nahmias A., Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann. Int. Med. 115:1991;520-526
5. Ashley R.L., Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin. Microbiol. Rev. 12:1999;1-8
6. Ashley R., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex viruses 1 and 2 in human sera. J. Clin. Microbiol. 26:1988;662-667
7. Balachandran N., Hutt-Fletcher L.M. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J. Virol. 54:1985;825-832
8. Becker T.M., Lee F., Daling J.R., Nahmias A.J. Seroprevalence of risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women. Sex Trans. Dis. 23:1996;138-144
9. Bergström T., Trybala E. Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology. 39:1996;176-184
10. Bernstein D., Bryson Y.J., Lovett M.A. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J. Med. Virol. 15:1985;251-263
11. Brown Z.A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L.A., Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Eng. J. Med. 324:1991;1247-1252
12. Corey, L., 1990. Genital herpes. In: Holmes, K.K., Mardh, P.A., Sparling, P.F., Wiesnere, P.J. (Eds.), Sexually Transmitted Diseases, 2nd ed. McGraw-Hill, New York, pp. 391-413.
13. Corey L., Handsfield H. Genital herpes and public health: addressing a global problem. JAMA. 283:2000;791-794
14. Cowan F.M., Johnson A.M., Ashley R., Corey L., Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J. Infect. Dis. 174:1996;470-475
15. Dalessio J., Ashley R. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J. Clin. Microbiol. 30:1992;1005-1007
16. Eberle R., Courtney R.J. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect. Immun. 31:1981;1062-1070
17. Eis-Hübinger A.M., Daume M., Matz B., Schneweis K.E. Evaluation of three glycoprotein G-2 based enzyme immunoassays for the detection of antibodies to herpes simplex virus type 2 in human sera. J. Clin. Microbiol. 37:1999;1242-1246
18. Field P.R., Ho D.W.T., Irving W.L., Isaacs D., Cunningham A.L. The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology. 25:1993;175-179
19. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., St. Louis M.E. Herpes simplex virus type 2 in the United States, 1976-1994. N. Eng. J. Med. 337:1997;1105-1111
20. Ho D.W.T., Field P.R., Irving W.L., Packham D.R., Cunningham A. Detection of immunoglobulin M antibodies to glycoprotein G-2 by Western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J. Clin. Microbiol. 31:1993;3157-3164
21. Holmberg S.D., Stewart J.A., Gerger A.R., Byers R.H., Lee F.K., O'Malley P.M., Nahmias A.J. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA. 259:1988;1048-1051
22. Koutsky L.A., Ashley R.L., Holmes K.K., Stevens C.L., Critchlow C.W., Kiviat N., Lipinsky C.M., Wølner-Hanssen P., Corey L. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex. Trans. Dis. 17:1990;90-94
23. Koutsky L.A., Stevens C.E., King P.A., Holmes K., Ashley R.L., Kiviat N.B., Critchlow C.W., Corey L. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. 326:1992;1533-1539
24. Kulhanjian J.A., Sorough V., Au D.S., Bronzan R.N., Yasukawa L.L., Weylman L.E., Arvin A.M., Prober C.G. Identification of women at unsuspected risk of primary infection with herpes simplex virus 2 during pregnancy. N. Eng. J. Med. 326:1992;916-920
25. Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann. Int. Med. 110:1989;882-887
26. Lee F.K., Coleman R.M., Pereira L., Bailey P.D., Tatsuno M., Nahmais A.J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol. 22:1985;641-644
27. Lee F.K., Pereira L., Griffin C., Reid E., Nahmias A. A novel glycoprotein for the detection of herpes simplex virus type 1-specific antibodies. J. Virol. Meth. 14:1986;114-118
28. Levi M., Rudén U., Carlberg H., Wahren B. The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies. J. Clin. Virol. 12:1999;243-252
29. Liljeqvist J., Svennerholm B., Bergström T. Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates. J. Clin. Microbiol. 38:2000;4517-4522
30. Liljeqvist J., Trybala E., Hoebeke J., Svennerholm B., Bergström T. Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex type 2 recognize type-specific antigenic determinants. J. Gen. Virol. 83:2002;157-165
31. Marsden H.S., Buckmaster A., Palfreyman J.W., Hope R.G., Minson A.C. Characterization of the 92, 000-Dalton glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:1984;547-554
32. Marsden H.S., MacAulay K., Murray J., Smith I.W. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J. Med. Virol. 56:1998;79-84
33. Mirza A., Stanberry L.R., Begue R.E. A 26-day-old neonate with apnea and cyanosis. Infect. Med. 13(2):1996;93-96
34. MMWR, 2002. Sexually Transmitted Diseases Treatment Guidelines 2002, vol. 51, No. RR-6. Centers for Disease Control and Prevention, pp. 12-17.
35. Nahmias, A.J., Lee, F.K., Pereira, L., Reid, E., Wickliffe, C., 1986. Monoclonal antibody immunoaffinity purified glycoproteins for the detection of herpes simplex virus 1 and 2 type-specific antibodies in serum. In: Roizman, B., Lopez, C. (Ed.), Human Herpesvirus Infections. Raven Press, New York, pp. 203-210.
36. Olofsson S., Jeansson S., Lycke E. Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein. J. Virol. 38:1981;564-570
37. Olofsson S., Lundström M., Marsden H., Jeansson S., Vahlne A. Characterization of a herpes simplex virus type-2 glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J. Gen. Virol. 67:1986;734-744
38. Parks D.L., Smith C.M., Rose J.M., Brandis J., Coates S.R. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J. Clin. Microbiol. 29:1991;778-781
39. Roizman R., Norrild B., Chan C., Pereira L. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology. 133:1984;242-247
40. Sanchez-Martinez D., Schmid D.S., Whittington W., Brown D., Reeves W.C., Chatterjee S., Whitley R.J. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J. Infect. Dis. 164:1991;1196-1199
41. Schmid D.S., Brown D.R., Nisenbaum R., Burke R.L., Alexander D., Ashley R., Pellett P.E., Reeves W.C. Limits in reliability of glycoprotein G-Based type-specific serologic assays for herpes simplex virus types 1 and 2. J. Clin. Microbiol. 37:1999;376-379
42. Stanberry L., Cunningham A., Mertz G., Mindel A., Peters B., Reitano M., Sacks S., Wald A., Wassilew S., Woolley P. New developments in the epidemiology, natural history and management of genital herpes. Antivir. Res. 42:1999;1-14
43. Su H.K., Fetherston D., Smith M.E., Courtney R.J. Orientation of the cleavage site of the herpes simplex virus glycoprotein G-2. J. Virol. 67:1993;2954-2959
44. Sullender W.A., Yasukawa L.L., Schwartz M., Pereira L., Hensleigh A., Prober C.G., Arvin A. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infections at delivery, and infants with neonatal herpes. J. Infect. Dis. 157:1988;164-171
45. Svennerholm B., Olofsson S., Jeansson S., Vahlne A., Lycke E. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J. Clin. Microbiol. 19:1984;235-239
46. Wald A., Zeh J., Selke S., Warren T., Ryncarz A.J., Ashley R., Krieger J.N., Corey L. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Eng. J. Med. 342:2000;844-850
47. Whitley R.J., Nahmias A.J., Visintine A.M., Flemming C.L., Alford C.A. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 66:1980;489-494